Dysmorphism
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
|
Congenital Abnormality
|
80
|
16
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Inflammatory Myofibroblastic Tumor
|
disease |
Pathological Conditions, Signs and Symptoms
|
Neoplastic Process
|
92
|
2
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Liposarcoma, Dedifferentiated
|
disease |
Neoplasms
|
Neoplastic Process
|
95
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Rhabdoid Tumor
|
disease |
Neoplasms
|
Neoplastic Process
|
103
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Atrophic condition of skin
|
group |
Pathological Conditions, Signs and Symptoms; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
111
|
4
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Alveolar rhabdomyosarcoma
|
disease |
Neoplasms
|
Neoplastic Process
|
115
|
1
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Desmoplastic
|
disease |
|
Disease or Syndrome
|
117
|
4
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Embryonal Rhabdomyosarcoma
|
disease |
Neoplasms
|
Neoplastic Process
|
121
|
8
|
0.020 |
None |
1.000 |
2 |
|
2009 |
2017 |
Electromyogram abnormal
|
phenotype |
|
Finding
|
130
|
12
|
0.100 |
None |
|
0 |
|
|
|
Muscular Dystrophy, Facioscapulohumeral
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases; Nervous System Diseases
|
Disease or Syndrome
|
143
|
3
|
0.600 |
None |
0.989 |
89 |
|
2006 |
2019 |
Soft Tissue Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
145
|
|
0.020 |
None |
1.000 |
2 |
|
2013 |
2014 |
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
145
|
21
|
0.300 |
None |
1.000 |
1 |
|
2016 |
2016 |
Adult Oligodendroglioma
|
disease |
Neoplasms
|
Neoplastic Process
|
154
|
19
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Childhood Oligodendroglioma
|
disease |
Neoplasms
|
Neoplastic Process
|
154
|
19
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Lordosis
|
phenotype |
Musculoskeletal Diseases
|
Disease or Syndrome
|
160
|
15
|
0.100 |
None |
|
0 |
|
|
|
Muscle damage
|
phenotype |
|
Acquired Abnormality
|
163
|
4
|
0.020 |
None |
1.000 |
2 |
|
2012 |
2017 |
Neuromuscular Diseases
|
group |
Nervous System Diseases
|
Disease or Syndrome
|
171
|
50
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Abnormality of cardiovascular system morphology
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Cardiovascular Diseases
|
Congenital Abnormality
|
198
|
13
|
0.100 |
None |
|
0 |
|
|
|
Paresis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Disease or Syndrome
|
216
|
49
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Creatine phosphokinase serum increased
|
phenotype |
|
Finding
|
228
|
43
|
0.100 |
None |
|
0 |
|
|
|
Leukemia, B-Cell
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
239
|
2
|
0.020 |
None |
1.000 |
2 |
|
2016 |
2018 |
Sarcoma of soft tissue
|
group |
Neoplasms
|
Neoplastic Process
|
258
|
6
|
0.020 |
None |
1.000 |
2 |
|
2012 |
2016 |
Well Differentiated Oligodendroglioma
|
disease |
Neoplasms
|
Neoplastic Process
|
270
|
22
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Muscular Dystrophy
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases; Nervous System Diseases
|
Disease or Syndrome
|
280
|
67
|
0.020 |
None |
1.000 |
2 |
|
2013 |
2013 |
oligodendroglioma
|
disease |
Neoplasms
|
Neoplastic Process
|
282
|
21
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |